A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?

R E Vandenbroucke1, E Dejonckheere, C Libert

  • 1Dept for Molecular Biomedical Research, VIB, Ghent University, Ghent (Zwijnaarde), Belgium.

Insights

Imbalances in matrix metalloproteinases (MMPs) contribute to lung diseases like COPD and asthma. MMP inhibitors offer therapeutic potential but face challenges due to lack of selectivity and incomplete understanding of MMP functions.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Pharmacology

Background:

  • Matrix metalloproteinases (MMPs) and their inhibitors maintain extracellular matrix homeostasis.
  • An imbalance between MMPs and their inhibitors is implicated in various pulmonary diseases.
  • Elevated net MMP activity is a hallmark of lung pathology.

Purpose of the Study:

  • To review the role of specific MMPs in lung disorders.
  • To explore the therapeutic potential of MMP inhibition for lung diseases.
  • To identify challenges and future directions for MMP-targeted therapies.

Main Methods:

  • Literature review of studies on MMPs in pulmonary diseases.
  • Analysis of existing data on MMP inhibitor efficacy and limitations.
  • Discussion of current knowledge gaps in MMP function.

Main Results:

  • MMP dysregulation is a common pathway in COPD, asthma, ILDs, and lung cancer.
  • MMP inhibition shows promise but lacks specificity.
  • Understanding individual MMP roles is crucial for effective treatment.

Conclusions:

  • Targeting MMPs is a viable therapeutic strategy for lung diseases.
  • Development of selective MMP inhibitors is essential.
  • Further research into MMP functions is needed to overcome clinical limitations.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
The Extracellular Matrix01:42

The Extracellular Matrix

Overview
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...